This isn't the same product though. This version of SleepCheck is for clinician use only, which is what they first suggested doing before they ended up going the D2C model. I always thought this was a much more appropriate use case for the tool, as marketing a product directly to consumers is vastly different to one to clinicians. Consumers will naturally compare it to other products already available, to which SleepCheck appears inferior, as it lacks many of the features that the other apps have (even if the other apps don't actually screen for OSA). And many consumers will not dig into the background of the product either to actually understand how it works, so there's also that trust factor that needs to be established (so in their eyes how do they know it even works, isn't just some scam). Whereas as a tool for clinicians, well patients will just use whatever their doctor prescribes them, and the clinicians will check out the studies behind it so they can be confident in using it. There's also the added advantage that they can add their own markup to it, so they're further incentivised to use/investigate it.
The company still can resurrect the D2C app, but it either needs a large amount of brand awareness (so everybody already knows what SleepCheck is), or they need to add more functionality to the app (recording their sleep, maybe highlighting patterns the AI has flagged, etc.).
